Status:
COMPLETED
Cartomerge Versus NavX Fusion in Catheter Ablation of Atrial Fibrillation
Lead Sponsor:
Barts & The London NHS Trust
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
Comparison of Two Strategies for Catheter Ablation of Atrial Fibrillation - a comparison of ablation guided by Cartomerge and NavX Fusion. 3D mapping systems are widely used in catheter ablation of AF...
Detailed Description
Patients are randomised to either NavX Fusion or Cartomerge. They undergo a standard catheter ablation procedure and data is collected. Both systems are routinely used in our clinical practise. This i...
Eligibility Criteria
Inclusion
- Be at least 18 years of age
- Be undergoing their first planned procedure for electrophysiology mapping and ablation in the left atrium of AF
- Be willing and able to sign the study specific informed consent
- Have a negative pregnancy test for female subjects of child bearing potential
Exclusion
- Have a left ventricular ejection fraction (LVEF) of \<40% as evaluated by pre-procedure TTE
- Have any contraindication or allergy to routine procedural medications or catheter materials
- Have any condition for which the investigator feels it is unsafe for the subject to undergo an invasive electrophysiology procedure (EP) catheterisation
- Be currently participating in another clinical research study
- Have any condition for which the subject's life expectancy is less than twelve months
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT01432743
Start Date
September 1 2007
End Date
April 1 2011
Last Update
September 13 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barts and the London NHS Trust
London, United Kingdom, EC1A 7BE